Clinical TrialsIncyte Reports Strong 1-Year Data for Povorcitinib in Hidradenitis Suppurat... Incyte Reports Strong 1-Year Data for Povorcitinib in Hidradenitis Suppurat... Read Post »
Clinical TrialsTaltz+Zepbound Outperforms Taltz Alone in PsA Patients with Obesity Taltz+Zepbound Outperforms Taltz Alone in PsA Patients with Obesity Read Post »
Clinical TrialsLilly’s EBGLYSS Reinforces Long-Term Disease Control in Atopic Dermatitis Lilly’s EBGLYSS Reinforces Long-Term Disease Control in Atopic Dermatitis Read Post »
Clinical TrialsSanofi Reports Phase 3 Success for Amlitelimab in Atopic Dermatitis Sanofi Reports Phase 3 Success for Amlitelimab in Atopic Dermatitis Read Post »
Clinical TrialsLenvima, Welireg Moves Closer to Approval with Japan Submission Lenvima, Welireg Moves Closer to Approval with Japan Submission Read Post »
New Drug ApprovalCHMP Recommends Five New Medicines for EU Approval in March 2026 CHMP Recommends Five New Medicines for EU Approval in March 2026 Read Post »
Clinical TrialsAstraZeneca Reports Positive Phase III Data for Tozorakimab in COPD AstraZeneca Reports Positive Phase III Data for Tozorakimab in COPD Read Post »
New Drug ApprovalChina Approves ENHERTU as First HER2 ADC for Neoadjuvant Breast Cancer China Approves ENHERTU as First HER2 ADC for Neoadjuvant Breast Cancer Read Post »
Clinical TrialsWave’s RNA Therapy WVE-007 Shows Early Fat-Loss Signal in INLIGHT Trial Wave’s RNA Therapy WVE-007 Shows Early Fat-Loss Signal in INLIGHT Trial Read Post »
New Drug ApprovalNovo Nordisk Wins FDA Approval for Once-Weekly Basal Insulin Awiqli Novo Nordisk Wins FDA Approval for Once-Weekly Basal Insulin Awiqli Read Post »
New Drug ApprovalFDA Grants Accelerated Approval to Rocket’s Kresladi Gene Therapy for... FDA Grants Accelerated Approval to Rocket’s Kresladi Gene Therapy for... Read Post »
Clinical TrialsEncoded Aligns with FDA on Pivotal ENDEAVOR Trial Design for ETX101 in Drav... Encoded Aligns with FDA on Pivotal ENDEAVOR Trial Design for ETX101 in Drav... Read Post »
Clinical TrialsCompass Updates COMP360 Pipeline, Targets FDA Filing in TRD Compass Updates COMP360 Pipeline, Targets FDA Filing in TRD Read Post »
New Drug ApprovalCorcept’s Relacorilant Combo Approved for Resistant Ovarian Cancer Corcept’s Relacorilant Combo Approved for Resistant Ovarian Cancer Read Post »
New Drug ApprovalFDA Clears Denali’s AVLAYAH, First Brain-Penetrant Therapy for Hunter... FDA Clears Denali’s AVLAYAH, First Brain-Penetrant Therapy for Hunter... Read Post »
Clinical TrialsInnovent Reports Positive Phase 3 Data for IBI302 in Wet AMD Innovent Reports Positive Phase 3 Data for IBI302 in Wet AMD Read Post »
Clinical TrialsSarepta Advances siRNA Pipeline with Early FSHD and DM1 Trial Data Sarepta Advances siRNA Pipeline with Early FSHD and DM1 Trial Data Read Post »
Clinical TrialsNovo Nordisk, TUL Report Positive UBT251 Phase 2 Results Novo Nordisk, TUL Report Positive UBT251 Phase 2 Results Read Post »
Clinical TrialsOcugen’s OCU410 Demonstrates 31% Lesion Reduction in Phase 2 GA Trial Ocugen’s OCU410 Demonstrates 31% Lesion Reduction in Phase 2 GA Trial Read Post »
Drugs Safety AlertAardvark Halts ARD-101 and ARD-201 Studies After QRS Signal in Safety Study Aardvark Halts ARD-101 and ARD-201 Studies After QRS Signal in Safety Study Read Post »
New Drug ApprovalJapan Approves Dupixent for Adults with Bullous Pemphigoid Japan Approves Dupixent for Adults with Bullous Pemphigoid Read Post »
New Drug ApprovalPharming’s Joenja Approved in Japan as First Treatment for APDS Pharming’s Joenja Approved in Japan as First Treatment for APDS Read Post »
Clinical TrialsDizal Reports Positive Phase 3 Sunvozertinib Results in NSCLC Dizal Reports Positive Phase 3 Sunvozertinib Results in NSCLC Read Post »
Drugs Safety AlertSeizure Risk Tied to Vitamin B6 Deficiency Prompts FDA Label Changes for Pa... Seizure Risk Tied to Vitamin B6 Deficiency Prompts FDA Label Changes for Pa... Read Post »
Generics New Drug ApprovalViatris’ Effexor SR Becomes First Approved Treatment for Generalized Anxi... Viatris’ Effexor SR Becomes First Approved Treatment for Generalized Anxi... Read Post »
Clinical TrialsApogee’s Zumilokibart Delivers 52-Week Control in Atopic Dermatitis Trial Apogee’s Zumilokibart Delivers 52-Week Control in Atopic Dermatitis Trial Read Post »
Clinical TrialsFDA Grants Priority Review to Ionis’ Zilganersen for Rare Alexander Disea... FDA Grants Priority Review to Ionis’ Zilganersen for Rare Alexander Disea... Read Post »
Clinical TrialsInsmed’s ARIKAYCE Hits Key Endpoints in Phase 3b ENCORE Trial Insmed’s ARIKAYCE Hits Key Endpoints in Phase 3b ENCORE Trial Read Post »
Clinical TrialsPfizer and Valneva Report >70% Efficacy for Lyme Vaccine Candidate in Phase... Pfizer and Valneva Report >70% Efficacy for Lyme Vaccine Candidate in Phase... Read Post »
Clinical TrialsRoche Stops Emugrobart in SMA and FSHD Trials After Weak Functional Outcome... Roche Stops Emugrobart in SMA and FSHD Trials After Weak Functional Outcome... Read Post »
Clinical TrialsBiohaven Completes Enrollment in Phase 2 Trial of Taldefgrobep for Obesity Biohaven Completes Enrollment in Phase 2 Trial of Taldefgrobep for Obesity Read Post »
Clinical TrialsBiogen-Eisai’s LEQEMBI Shows Strong Real-World Treatment Persistence ... Biogen-Eisai’s LEQEMBI Shows Strong Real-World Treatment Persistence ... Read Post »
Clinical TrialsSerum Institute Taps Eveliqure Platform for Anti-Diarrhoeal Vaccines in Chi... Serum Institute Taps Eveliqure Platform for Anti-Diarrhoeal Vaccines in Chi... Read Post »
New Drug ApprovalNivolumab Plus AVD Approved by FDA as Frontline Therapy for Advanced cHL Nivolumab Plus AVD Approved by FDA as Frontline Therapy for Advanced cHL Read Post »
New Drug ApprovalFDA Approves IMCIVREE as First Therapy for Acquired Hypothalamic Obesity FDA Approves IMCIVREE as First Therapy for Acquired Hypothalamic Obesity Read Post »
Clinical TrialsChugai Files in Japan for Ocular Implant Component of Ranibizumab Port Deli... Chugai Files in Japan for Ocular Implant Component of Ranibizumab Port Deli... Read Post »
New Drug ApprovalWegovy HD Approved by FDA After Trials Show ~21% Weight Loss Wegovy HD Approved by FDA After Trials Show ~21% Weight Loss Read Post »
New Drug ApprovalFDA Approves GSK’s Lynavoy as First Treatment for PBC-Related Itch FDA Approves GSK’s Lynavoy as First Treatment for PBC-Related Itch Read Post »
Clinical TrialsPfizer’s TALZENNA Combo Hits rPFS Goal in TALAPRO-3 Pfizer’s TALZENNA Combo Hits rPFS Goal in TALAPRO-3 Read Post »
Drugs Safety AlertEisai Pulls Tazverik in Japan After Global Safety Review Eisai Pulls Tazverik in Japan After Global Safety Review Read Post »
Clinical TrialsSobi Explores Gamifant for Interferon-Gamma–Driven Sepsis in New Phase 2a... Sobi Explores Gamifant for Interferon-Gamma–Driven Sepsis in New Phase 2a... Read Post »
ResearchGrifols Detects Parkinson’s Disease Changes Years Before Diagnosis Grifols Detects Parkinson’s Disease Changes Years Before Diagnosis Read Post »
New Drug ApprovalJ&J’s Oral IL-23 Therapy ICOTYDE Wins FDA Approval for Plaque Psorias... J&J’s Oral IL-23 Therapy ICOTYDE Wins FDA Approval for Plaque Psorias... Read Post »
Clinical TrialsRhythm’s EMANATE Misses Endpoint, Highlights Subgroup Benefit Rhythm’s EMANATE Misses Endpoint, Highlights Subgroup Benefit Read Post »
Clinical TrialsPfizer’s Next-Gen CDK4 Inhibitor Shows Phase 2 Breast Cancer Benefit Pfizer’s Next-Gen CDK4 Inhibitor Shows Phase 2 Breast Cancer Benefit Read Post »
Clinical TrialsFDA Finds No Bioequivalence Deficiencies in NRx Preservative-Free Ketamine ... FDA Finds No Bioequivalence Deficiencies in NRx Preservative-Free Ketamine ... Read Post »
Drugs Safety AlertSCFE Cases Prompt BioMarin to Halt Select VOXZOGO Trials in Rare Growth Dis... SCFE Cases Prompt BioMarin to Halt Select VOXZOGO Trials in Rare Growth Dis... Read Post »
Clinical TrialsStructure Therapeutics’ Aleniglipron Demonstrates Strong Weight Loss Structure Therapeutics’ Aleniglipron Demonstrates Strong Weight Loss Read Post »
Clinical TrialsLilly Advances EBGLYSS Pediatric Indication After Positive ADorable-1 Trial... Lilly Advances EBGLYSS Pediatric Indication After Positive ADorable-1 Trial... Read Post »
Clinical TrialsCytomX Eyes Registrational Path for Varseta-M After Encouraging CRC Data CytomX Eyes Registrational Path for Varseta-M After Encouraging CRC Data Read Post »
